LATEST
England’s Fin Smith facing make-or-break fitness test before Australia clash✦America Votes in High-Stakes Midterms✦Cattle Diverge on Monday, with Feeders Finding Strength and Live Cattle Weaker✦Soybeans Starting with Weakness on Tuesday✦Abbott: Hinojosa 'makes Talarico look almost conservative'✦
Tue, Nov 3, 2026
Loading weather...
Markets

Rhythm Pharmaceuticals, Inc. Reports Third Quarter 2026 Net Product Revenue of $92.1 million

Rhythm Pharmaceuticals, Inc. reported its financial results for the third quarter ended September 30, 2026, with net pro...

By Dhallo News · November 3, 2026 at 10:42 PM IST

Rhythm Pharmaceuticals, Inc. reported its financial results for the third quarter ended September 30, 2026, with net product revenue from global sales of IMCIVREE reaching $92.1 million, representing a 29% increase from the prior quarter. The company's net loss attributable to co

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

Cattle Diverge on Monday, with Feeders Finding Strength and Live Cattle Weaker

Live cattle futures fell anywhere from a nickel to $1.25 across most contracts o...

Read Article »

Soybeans Starting with Weakness on Tuesday

Soybeans are trading 3 to 4 cents lower early on Tuesday. Futures were under pre...

Read Article »

SOPHiA GENETICS SA Reports Third Quarter 2026 Financial Results

SOPHiA GENETICS SA reported financial results for the third quarter ended Septem...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.